Alvotech's lenders lower interest on senior secured term loan facility

Reykjavik, iceland (june 26, 2025) — alvotech (nasdaq: alvo, alvo sdb, the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under the company's existing senior secured term loan facility, including goldentree asset management (collectively, the “lenders”), have agreed to reduce the rate of interest on its existing senior secured term loan facility (the “facility”). the agreement will lower alvotech's interest payments in the first 12 months by an estimated us$8.2 million. this is an outcome of alvotech's sustained operational improvements and strengthened financial performance over the past year.
ALVO Ratings Summary
ALVO Quant Ranking